ATE316979T1 - Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt - Google Patents
Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammtInfo
- Publication number
- ATE316979T1 ATE316979T1 AT97928617T AT97928617T ATE316979T1 AT E316979 T1 ATE316979 T1 AT E316979T1 AT 97928617 T AT97928617 T AT 97928617T AT 97928617 T AT97928617 T AT 97928617T AT E316979 T1 ATE316979 T1 AT E316979T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- coagulase
- binding protein
- staphylococus
- negative
- Prior art date
Links
- 101710128530 Fibrinogen-binding protein Proteins 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108010065152 Coagulase Proteins 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 2
- 102000053602 DNA Human genes 0.000 abstract 2
- 108020004511 Recombinant DNA Proteins 0.000 abstract 2
- 241000295644 Staphylococcaceae Species 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 102000008946 Fibrinogen Human genes 0.000 abstract 1
- 108010049003 Fibrinogen Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000027455 binding Effects 0.000 abstract 1
- 238000010352 biotechnological method Methods 0.000 abstract 1
- 229940012952 fibrinogen Drugs 0.000 abstract 1
- 102000025748 fibrinogen binding proteins Human genes 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9602496A SE9602496D0 (sv) | 1996-06-20 | 1996-06-20 | Method and means for producing a fibrinogen binding protein and its use in biotechnology |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE316979T1 true ATE316979T1 (de) | 2006-02-15 |
Family
ID=20403140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97928617T ATE316979T1 (de) | 1996-06-20 | 1997-06-18 | Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US6733758B1 (enExample) |
| EP (1) | EP0922056B1 (enExample) |
| JP (1) | JP4173549B2 (enExample) |
| AT (1) | ATE316979T1 (enExample) |
| AU (1) | AU3282597A (enExample) |
| CA (1) | CA2294433A1 (enExample) |
| DE (1) | DE69735207T2 (enExample) |
| ES (1) | ES2258280T3 (enExample) |
| SE (1) | SE9602496D0 (enExample) |
| WO (1) | WO1997048727A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6685943B1 (en) | 1997-01-21 | 2004-02-03 | The Texas A&M University System | Fibronectin binding protein compositions and methods of use |
| US6380370B1 (en) * | 1997-08-14 | 2002-04-30 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| AU1537699A (en) * | 1997-11-26 | 1999-06-15 | Bioresearch Ireland a division of Eolas - The Irish Science and Technology Agency | Extracellular matrix-binding proteins from (staphylococcus aureus) |
| WO2000012131A1 (en) * | 1998-08-31 | 2000-03-09 | Inhibitex, Inc. | Multicomponent vaccines |
| US6635473B1 (en) * | 1998-08-31 | 2003-10-21 | The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | Polypeptides and polynucleotides from coagulase-negative staphylococci |
| CA2341177A1 (en) * | 1998-08-31 | 2000-03-09 | Inhibitex, Inc. | Staphylococcal immunotherapeutics via donor selection and donor stimulation |
| US6692739B1 (en) | 1998-08-31 | 2004-02-17 | Inhibitex, Inc. | Staphylococcal immunotherapeutics via donor selection and donor stimulation |
| US6703025B1 (en) | 1998-08-31 | 2004-03-09 | Inhibitex, Inc. | Multicomponent vaccines |
| US20040038327A1 (en) * | 1999-08-31 | 2004-02-26 | Foster Timothy J. | Antibodies to polypeptides from coagulase-negative staphylococci |
| EP2320233A1 (en) | 2001-06-15 | 2011-05-11 | Inhibitex, Inc. | Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| CA2478029A1 (en) * | 2002-03-05 | 2003-09-18 | Inhibitex, Inc. | Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins |
| CA2517439C (en) | 2003-03-07 | 2013-07-23 | Wyeth Holdings Corporation | Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| ES2730275T3 (es) | 2004-09-22 | 2019-11-11 | Glaxosmithkline Biologicals Sa | Composición inmunógena para uso en vacunación contra estafilococos |
| KR101541383B1 (ko) | 2006-03-30 | 2015-08-03 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 면역원성 조성물 |
| WO2007127339A2 (en) * | 2006-04-26 | 2007-11-08 | Tyco Healthcare Group Lp | Multi-stage microporation device |
| SI2445522T1 (sl) | 2009-06-22 | 2017-10-30 | Wyeth Llc | Imunogeni sestavki antigenov Staphylococcusa aureusa |
| CA2768204A1 (en) | 2009-07-15 | 2011-01-20 | Aimm Therapeutics B.V. | Gram-positive bacteria specific binding compounds |
| GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| KR20230031322A (ko) | 2020-06-27 | 2023-03-07 | 크레센타 바이오사이언시즈 | 세포 물질대사를 조정하는 화합물의 조성물 및 사용 방법 |
| US12138243B2 (en) | 2021-12-31 | 2024-11-12 | Crescenta Biosciences | Antiviral use of FABP4 modulating compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3583987D1 (de) | 1984-11-06 | 1991-10-10 | Thomae Gmbh Dr K | Antibiotisches polypeptid, verfahren zu seiner herstellung und seine verwendung. |
| ATE95187T1 (de) * | 1988-07-15 | 1993-10-15 | Thomae Gmbh Dr K | Verfahren zur gewinnung, isolierung und reinigung von epidermin. |
| US5055455A (en) * | 1988-09-28 | 1991-10-08 | Brigham And Women's Hospital | Capsular polysaccharide adhesin antigen, preparation, purification and use |
| US5571511A (en) * | 1990-10-22 | 1996-11-05 | The U.S. Government | Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
| EP0621875B1 (en) * | 1992-09-21 | 2002-03-27 | Alfa-Laval Agri International Ab | Fibrinogen binding protein |
| IL109410A0 (en) * | 1993-04-30 | 1994-07-31 | Ell Lilly & Company | Fema gene of staphylococcus epidermidis, fema protein, and vectors and microorganisms comprising the fema gene |
| US6107068A (en) * | 1995-12-22 | 2000-08-22 | The University Of British Columbia | Coenzyme A disulfide reductase, and inhibitors thereof useful as antimicrobial agents |
-
1996
- 1996-06-20 SE SE9602496A patent/SE9602496D0/xx unknown
-
1997
- 1997-06-18 EP EP97928617A patent/EP0922056B1/en not_active Expired - Lifetime
- 1997-06-18 WO PCT/SE1997/001091 patent/WO1997048727A1/en not_active Ceased
- 1997-06-18 JP JP50281998A patent/JP4173549B2/ja not_active Expired - Fee Related
- 1997-06-18 CA CA002294433A patent/CA2294433A1/en not_active Abandoned
- 1997-06-18 DE DE69735207T patent/DE69735207T2/de not_active Expired - Fee Related
- 1997-06-18 AT AT97928617T patent/ATE316979T1/de not_active IP Right Cessation
- 1997-06-18 US US09/147,405 patent/US6733758B1/en not_active Expired - Lifetime
- 1997-06-18 ES ES97928617T patent/ES2258280T3/es not_active Expired - Lifetime
- 1997-06-18 AU AU32825/97A patent/AU3282597A/en not_active Abandoned
-
2004
- 2004-03-23 US US10/806,288 patent/US7160990B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2294433A1 (en) | 1997-12-24 |
| SE9602496D0 (sv) | 1996-06-20 |
| JP2001503609A (ja) | 2001-03-21 |
| DE69735207T2 (de) | 2006-11-02 |
| JP4173549B2 (ja) | 2008-10-29 |
| US20040209326A1 (en) | 2004-10-21 |
| WO1997048727A1 (en) | 1997-12-24 |
| EP0922056B1 (en) | 2006-02-01 |
| AU3282597A (en) | 1998-01-07 |
| US7160990B2 (en) | 2007-01-09 |
| US6733758B1 (en) | 2004-05-11 |
| ES2258280T3 (es) | 2006-08-16 |
| EP0922056A1 (en) | 1999-06-16 |
| DE69735207D1 (de) | 2006-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE316979T1 (de) | Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt | |
| DE69534588D1 (de) | Protocadherin-proteine und verwendungen davon | |
| DK0397633T3 (da) | Fibronectinbindende protein samt fremstilling deraf | |
| AU2001294541A1 (en) | Mammalian genes; related reagents and methods | |
| ATE177754T1 (de) | Fragmente von prion proteinen. | |
| DE69739996D1 (de) | Methoden und Zusammensetzungen zur Herstellung von Polypeptiden | |
| ATE345387T1 (de) | Verbindungen und verfahren für therapie und diagnose von lungenkrebs | |
| DE59309458D1 (de) | Synthetische Peptide, Antikörper dagegen und ihre Verwendung | |
| ATE229977T1 (de) | Peptide mit antiproliferativen eigenschaften | |
| TW200716746A (en) | Methods for identifying a compound modulating the binding between polypeptides | |
| WO1995011975A3 (en) | Retroviral superantigens, superantigen peptides, and methods of use | |
| DE69535855D1 (de) | Calciumbindende rekombinante antikörper gegen protein c | |
| NO177570B (no) | Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper | |
| WO1994026891A3 (en) | Purified mammalian flt3 ligands and agonists and antagonists thereof | |
| EP0990703A4 (en) | NEW POLYPEPTIDE, FOR CODING DNA AND THEIR USE | |
| SE9003374D0 (sv) | A collagen binding protein as well as its preparation | |
| AU4136797A (en) | Novel semaphorin gene: semaphorin y | |
| CY1110308T1 (el) | Μοριο νουκλεϊνικου οξεος, το οποιο περιλαμβανει μια κωδικευσουσα για αιμοκυανινη ακολουθια νουκλεϊνικου οξεος και τουλαχιστον μια ακολουθια ιντρονιου | |
| DE69534596D1 (de) | Epil/plazentin | |
| CA2218755A1 (en) | Monoclonal antibody to human beta 2 integrin alpha subunit | |
| ATE351909T1 (de) | Neue peptidfragmente zur reinigung von proteinen | |
| SE0003573D0 (sv) | Method and means for producing novel von Willebrand factor binding proteins and their use in biotechnology | |
| SE9302856D0 (sv) | Method and means for producing a plasmapeotein-binding protein | |
| EP1679372A4 (en) | NEW PLEXIN POLYPEPTIDE, THIS CODING DNA AND USE THEREOF | |
| UA35624C2 (uk) | МОЛЕКУЛА ДНК, ЩО КОДУЄ ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, ВЕКТОР, L-КЛІТИНА, ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, СПОСІБ ЙОГО ОТРИМАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, МОНОКЛОНАЛЬНЕ АНТИТІЛО |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |